Pancreatic cancer stem cells - insights and perspectives

被引:32
作者
Hermann, Patrick C. [1 ]
Mueller, Maria-Theresa [1 ]
Heeschen, Christopher [1 ]
机构
[1] Spanish Natl Canc Res Ctr CNIO, Stem Cells & Canc Unit, Clin Res Programme, Madrid, Spain
关键词
cancer; pancreas; stem cells; targeted therapy; tumour-initiating cell; METASTATIC BREAST-CANCER; TUMOR-INITIATING CELLS; LUNG-CANCER; HEMATOPOIETIC STEM; MYELOID-LEUKEMIA; MELANOMA-CELLS; PHASE-II; IDENTIFICATION; EXPRESSION; CXCR4;
D O I
10.1517/14712590903246362
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background: Solid tumours are the most common cancers and represent a major therapeutic challenge. The cancer stem cell (CSC) hypothesis is an attractive model to explain the functional heterogeneity commonly observed in solid tumours. It proposes a hierarchical organization of tumours, in which a subpopulation of stem cell-like cells sustains tumour growth, metastasis and resistance to therapy. Objective: Here we review the most recent advances in the CSC field, with particular emphasis on pancreatic cancer as one of the deadliest human tumours, and highlight open questions and caveats to be addressed in future studies. Methods: This review focuses on the role of CSC in the promotion and metastasis of solid tumours and summarizes recent findings regarding the targeting of signalling pathways that are of particular importance for the maintenance and the elimination of CSC as the proposed root of the tumour. Results/conclusions: There is increasing evidence that solid tumours, including pancreatic cancer, are hierarchically organized and sustained by a distinct subpopulation of CSC. Direct evidence for the CSC hypothesis has emerged from mouse models only recently. While the clinical relevance of CSC remains a fundamental issue, current findings suggest that specific targeting of these cells is possible and therapeutically relevant.
引用
收藏
页码:1271 / 1278
页数:8
相关论文
共 42 条
[1]   Prospective identification of tumorigenic breast cancer cells [J].
Al-Hajj, M ;
Wicha, MS ;
Benito-Hernandez, A ;
Morrison, SJ ;
Clarke, MF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) :3983-3988
[2]   The significance of cancer cell expression of the chemokine receptor CXCR4 [J].
Balkwill, F .
SEMINARS IN CANCER BIOLOGY, 2004, 14 (03) :171-179
[3]   Glioma stem cells promote radioresistance by preferential activation of the DNA damage response [J].
Bao, Shideng ;
Wu, Qiulian ;
McLendon, Roger E. ;
Hao, Yueling ;
Shi, Qing ;
Hjelmeland, Anita B. ;
Dewhirst, Mark W. ;
Bigner, Darell D. ;
Rich, Jeremy N. .
NATURE, 2006, 444 (7120) :756-760
[4]   Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell [J].
Bonnet, D ;
Dick, JE .
NATURE MEDICINE, 1997, 3 (07) :730-737
[5]  
Cameron MD, 2000, CANCER RES, V60, P2541
[6]   Cancer stem cells: Models and concepts [J].
Dalerba, Piero ;
Cho, Robert W. ;
Clarke, Michael F. .
ANNUAL REVIEW OF MEDICINE, 2007, 58 :267-284
[7]   Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: A new paradigm for combination therapy in solid cancers [J].
Feldmann, Georg ;
Dhara, Surajit ;
Fendrich, Volker ;
Bedja, Djahida ;
Beaty, Robert ;
Mullendore, Michael ;
Karikari, Collins ;
Alvarez, Hector ;
Iacobuzio-Donahue, Christine ;
Jimeno, Antonio ;
Gabrielson, Kathleen L. ;
Matsui, William ;
Maitra, Anirban .
CANCER RESEARCH, 2007, 67 (05) :2187-2196
[8]   Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer [J].
Hermann, Patrick C. ;
Huber, Stephan L. ;
Herrler, Tanja ;
Aicher, Alexandra ;
Ellwart, Joachim W. ;
Guba, Markus ;
Bruns, Christiane J. ;
Heeschen, Christopher .
CELL STEM CELL, 2007, 1 (03) :313-323
[9]   BMP4 regulates pancreatic progenitor cell expansion through Id2 [J].
Hua, H ;
Zhang, YQ ;
Dabernat, S ;
Kritzik, M ;
Dietz, D ;
Sterling, L ;
Sarvetnick, N .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (19) :13574-13580
[10]   Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer [J].
Hurwitz, H ;
Fehrenbacher, L ;
Novotny, W ;
Cartwright, T ;
Hainsworth, J ;
Heim, W ;
Berlin, J ;
Baron, A ;
Griffing, S ;
Holmgren, E ;
Ferrara, N ;
Fyfe, G ;
Rogers, B ;
Ross, R ;
Kabbinavar, F .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23) :2335-2342